Patent · US Active

Cell model and method for screening c-Fms kinase inhibitors

US9683988B2 · kind B2 · utility

0Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2012
Grant dateJun 20, 2017
Priority date
Expiry dateJul 26, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides a cell model and a method for screening c-Fms tyrosine kinase inhibitors. Specifically, the present invention provides a cell that expresses macrophage colony stimulating factor receptor and STAT1 protein simultaneously. The present invention further provides a method for screening c-Fms tyrosine kinase inhibitors, a method for evaluating the inhibiting activity of a compound or a composition against c-Fms tyrosine kinase, and use of the cell in screening c-Fms tyrosine kinase inhibitors. The cell model established in the present invention is sensitive, highly effective and reliable, and can be used in high-throughput screening and/or high-content screening of c-Fms tyrosine kinase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.